• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Healthcare·SASTASUNDR.NS
Share

Health X Platform Limited Stocks

₹ 322.45Last Updated 25.05.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

₹ 94.39M

₹ 322.45
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Established in 1989 and headquartered in Kolkata, India, Sastasundar Ventures Limited manages a comprehensive digital healthcare ecosystem across the country. In addition to its core healthcare activities, the company provides a variety of financial services, including loan financing, investments in shares and other securities, financial advisory, wealth management, and distribution. It also runs online portals such as sastasundar.com and retailershakti.com for the promotion of healthcare products and pathology services. Furthermore, Sastasundar offers crucial diagnostic services, encompassing both pathological and radiological investigations. Its business also extends to distributing pharmaceuticals and wellness items, delivering personalized health supplements, offering diet counseling, and providing health information. The company adopted its current name, Sastasundar Ventures Limited, in November 2016, having previously operated as Microsec Financial Services Limited.

Company Valuation

Undervalued
6/7

Considering past and projected metrics, the stock is 'cheaper' than its peers. In particular, the stock is reasonably priced on P/E, of fair value on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of SASTASUNDR.NS is 457 and suggests 62% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation t

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

25.07.2026 08:00

AI Spending Threatens the Creditworthiness of Amazon, Meta, and Alphabet — Moody’s

25.07.2026 06:24

In July, four out of five of the short seller's bets from *The Short Game* paid off. Which ones?

25.07.2026 05:59

Nvidia and Palantir Urged the U.S. Not to Restrict "Open" AI Models Following China's Breakthrough

25.07.2026 05:03

SpaceX has successfully tested the Starship rocket for the first time since its IPO

25.07.2026 04:30

Paramount has put its merger with Warner Bros. on hold for nearly a year

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026